Skip to main content

Advertisement

SpringerLink
Log in

Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis

  • IM - CASE RECORD
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Kyle RA, Larson DR, Kurtin PJ et al (2019) Incidence of AL amyloidosis in Olmsted County, Minnesota, 1990 through 2015. Mayo Clin Proc 94:465–471. https://doi.org/10.1016/j.mayocp.2018.08.041

    Article  PubMed  Google Scholar 

  2. Perfetto F, Cappelli F, Bergesio F et al (2013) Cardiac amyloidosis: the heart of the matter. Intern Emerg Med 8:191–203

    Article  Google Scholar 

  3. Van Gameren II, Hazenberg BPC, Bijzet J, Van Rijswijk MH (2006) Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 54:2015–2021. https://doi.org/10.1002/art.21902

    Article  PubMed  Google Scholar 

  4. Wechalekar AD, Schonland SO, Kastritis E et al (2013) A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood 121:3420–3427. https://doi.org/10.1182/blood-2012-12-473066

    Article  PubMed  CAS  Google Scholar 

  5. Palladini G, Sachchithanantham S, Milani P et al (2015) A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis. Blood 126:612–615. https://doi.org/10.1182/blood-2015-01-620302

    Article  PubMed  CAS  Google Scholar 

  6. Vaxman I, Gertz M (2019) Recent advances in the diagnosis, risk stratification, and management of systemic light-chain amyloidosis. Acta Haematol 141:93–106

    Article  CAS  Google Scholar 

  7. Palladini G, Milani P, Foli A et al (2014) Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients. Leukemia 28:2311–2316. https://doi.org/10.1038/leu.2014.227

    Article  PubMed  CAS  Google Scholar 

  8. Sobol U, Stiff P (2014) Neurologic aspects of plasma cell disorders. Handbook of clinical neurology. Elsevier B.V., Amsterdam, pp 1083–1099

    Google Scholar 

  9. Matsuda M, Gono T, Morita H et al (2011) Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. Eur J Neurol 18:604–610. https://doi.org/10.1111/j.1468-1331.2010.03215.x

    Article  PubMed  CAS  Google Scholar 

  10. Rajkumar SV, Hayman SR, Lacy MQ et al (2005) Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Blood 106:4050–4053. https://doi.org/10.1182/blood-2005-07-2817

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Rotter J, Dowlati E, Jha RT et al (2019) Primary cervical spine AL-κ amyloidoma: a case report and review of the literature. Neuropathology 39:231–239. https://doi.org/10.1111/neup.12556

    Article  PubMed  CAS  Google Scholar 

  12. Sadek I, Kapoor P, Gertz MA, Kumar S (2010) An unusual neurological complication of light chain amyloidosis: images in haematology. Br J Haematol 148:816. https://doi.org/10.1111/j.1365-2141.2009.07897.x

    Article  PubMed  Google Scholar 

  13. Chantry A, Kazmi M, Barrington S et al (2017) Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol 178:380–393. https://doi.org/10.1111/bjh.14827

    Article  PubMed  Google Scholar 

  14. Rahmouni A, Divine M, Mathieu D et al (1993) Detection of multiple myeloma involving the spine: efficacy of fat- suppression and contrast-enhanced MR imaging. Am J Roentgenol 160:1049–1052. https://doi.org/10.2214/ajr.160.5.8470574

    Article  CAS  Google Scholar 

  15. Glaudemans AWJM, Slart RHJA, Noordzij W et al (2013) Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis. Eur J Nucl Med Mol Imaging 40:1095–1101. https://doi.org/10.1007/s00259-013-2375-1

    Article  PubMed  CAS  Google Scholar 

  16. Farrell K, Stobo DB, Soutar R (2011) Cervical amyloidoma successfully treated with bortezomib and dexamethasone. J Clin Oncol 29:e512–e513. https://doi.org/10.1200/JCO.2011.34.6452

    Article  PubMed  Google Scholar 

  17. Samandouras G, Teddy PJ, Cadoux-Hudson T, Ansorge O (2006) Amyloid in neurosurgical and neurological practice. J Clin Neurosci 13:159–167

    Article  CAS  Google Scholar 

  18. Barison A, Aquaro GD, Pugliese NR et al (2015) Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging. J Intern Med 277:605–614. https://doi.org/10.1111/joim.12324

    Article  PubMed  CAS  Google Scholar 

  19. Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132:1570–1579. https://doi.org/10.1161/CIRCULATIONAHA.115.016567

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Berg AM, Anderson JJ, Chipkin SR et al (1994) Autonomic neuropathy in AL (primary) amyloidosis and its effect on survival. Amyloid 1:39–46. https://doi.org/10.3109/13506129409148623

    Article  CAS  Google Scholar 

  21. Dispenzieri A, Dingli D, Kumar SK et al (2010) Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs. Am J Hematol 85:757–759. https://doi.org/10.1002/ajh.21822

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy

    Federico Perfetto, Massimo Di Gioia, Marco Allinovi, Giulia Taborchi & Francesco Cappelli

  2. Department of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, Largo Brambilla 3, 50134, Florence, Italy

    Silvia Casagrande & Alessandro Barilaro

  3. Pathological Anatomy Unit, Careggi University Hospital, Florence, Italy

    Raffaella Santi

  4. Nephrology Unit, Careggi University Hospital, Florence, Italy

    Marco Allinovi

  5. Unit of Spine Surgery, Careggi University Hospital, Florence, Italy

    Stefano Romoli & Andrea Boschi

  6. Neuroradiology Unit, Careggi University Hospital, Florence, Italy

    Ilaria Desideri

  7. Interventional Structural Cardiology Division, Careggi University Hospital, Florence, Italy

    Francesco Cappelli

  8. Syncope Unit, Geriatric Intensive Care Medicine, Hypertension Centre, Careggi University Hospital, University of Florence, Florence, Italy

    Andrea Ungar

Authors
  1. Federico Perfetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Casagrande
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Barilaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo Di Gioia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raffaella Santi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marco Allinovi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefano Romoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andrea Boschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ilaria Desideri
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Giulia Taborchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Andrea Ungar
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Francesco Cappelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvia Casagrande.

Ethics declarations

Conflict of interest

The author declares that they have no competing interests.

Statement of human and animal rights

This article does not contain any studies with animal or human subjects performed by any of the authors.

Informed consent

Obtained from the patient for his anonymized data to be published.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perfetto, F., Casagrande, S., Barilaro, A. et al. Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis. Intern Emerg Med 16, 1927–1933 (2021). https://doi.org/10.1007/s11739-020-02489-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-020-02489-8

Search

Navigation